194 related articles for article (PubMed ID: 31958523)
21. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
22. Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.
Schmidt SAJ; Vestergaard M; Baggesen LM; Pedersen L; Schønheyder HC; Sørensen HT
Vaccine; 2017 Oct; 35(42):5589-5596. PubMed ID: 28874322
[TBL] [Abstract][Full Text] [Related]
23. Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in U.S. children and adults.
Lee HH; Patel KR; Singam V; Rastogi S; Silverberg JI
Br J Dermatol; 2020 Feb; 182(2):327-334. PubMed ID: 31049925
[TBL] [Abstract][Full Text] [Related]
24. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
[TBL] [Abstract][Full Text] [Related]
25. The Inpatient Burden of Autoimmune Blistering Disease in US Children: Analysis of Nationwide Inpatient Sample Data.
Ren Z; Hsu DY; Silverberg NB; Silverberg JI
Am J Clin Dermatol; 2017 Apr; 18(2):287-297. PubMed ID: 28211027
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.
Kim M; Choi KH; Hwang SW; Lee YB; Park HJ; Bae JM
J Am Acad Dermatol; 2017 Jan; 76(1):40-48. PubMed ID: 27793451
[TBL] [Abstract][Full Text] [Related]
27. Incidence of herpes zoster and its complications in Germany, 2005-2009.
Hillebrand K; Bricout H; Schulze-Rath R; Schink T; Garbe E
J Infect; 2015 Feb; 70(2):178-86. PubMed ID: 25230396
[TBL] [Abstract][Full Text] [Related]
28. [Surveillance and epidemiology of Herpes Zoster in Spain.].
Masa-Calles J; López-Perea N; Vila Cordero B; Carmona R
Rev Esp Salud Publica; 2021 Jun; 95():. PubMed ID: 34168107
[TBL] [Abstract][Full Text] [Related]
29. Inpatient burden of juvenile dermatomyositis among children in the United States.
Kwa MC; Silverberg JI; Ardalan K
Pediatr Rheumatol Online J; 2018 Nov; 16(1):70. PubMed ID: 30424778
[TBL] [Abstract][Full Text] [Related]
30. Herpes zoster in Germany: quantifying the burden of disease.
Ultsch B; Siedler A; Rieck T; Reinhold T; Krause G; Wichmann O
BMC Infect Dis; 2011 Jun; 11():173. PubMed ID: 21679419
[TBL] [Abstract][Full Text] [Related]
31. Population-based study of the epidemiology of herpes zoster in Korea.
Kim YJ; Lee CN; Lim CY; Jeon WS; Park YM
J Korean Med Sci; 2014 Dec; 29(12):1706-10. PubMed ID: 25469074
[TBL] [Abstract][Full Text] [Related]
32. Costs of Care for Hospitalization for Pemphigus in the United States.
Hsu D; Brieva J; Silverberg JI
JAMA Dermatol; 2016 Jun; 152(6):645-54. PubMed ID: 26865293
[TBL] [Abstract][Full Text] [Related]
33. Hospitalization for Varicella and Zoster in Children with Inflammatory Bowel Disease.
Adams DJ; Nylund CM
J Pediatr; 2016 Apr; 171():140-5. PubMed ID: 26826886
[TBL] [Abstract][Full Text] [Related]
34. Herpes zoster: Burden of disease in France.
Gonzalez Chiappe S; Sarazin M; Turbelin C; Lasserre A; Pelat C; Bonmarin I; Chosidow O; Blanchon T; Hanslik T
Vaccine; 2010 Nov; 28(50):7933-8. PubMed ID: 20946861
[TBL] [Abstract][Full Text] [Related]
35. The burden of disease of Herpes Zoster in Tuscany.
Levi M; Bellini I; Capecchi L; Pieri L; Bechini A; Boccalini S; Callaioli S; Gasparini R; Panatto D; Tiscione E; Bonanni P
Hum Vaccin Immunother; 2015; 11(1):185-91. PubMed ID: 25483534
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of herpes zoster in patients with coeliac disease - nationwide cohort study.
Ludvigsson JF; Choung RS; Marietta EV; Murray JA; Emilsson L
Scand J Public Health; 2018 Dec; 46(8):859-866. PubMed ID: 28701089
[TBL] [Abstract][Full Text] [Related]
37. Herpes zoster in psoriasis patients treated with tofacitinib.
Winthrop KL; Lebwohl M; Cohen AD; Weinberg JM; Tyring SK; Rottinghaus ST; Gupta P; Ito K; Tan H; Kaur M; Egeberg A; Mallbris L; Valdez H
J Am Acad Dermatol; 2017 Aug; 77(2):302-309. PubMed ID: 28711084
[TBL] [Abstract][Full Text] [Related]
38. Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014.
Imafuku S; Dormal G; Goto Y; Jégou C; Rosillon D; Matsuki T
J Dermatol; 2020 Mar; 47(3):236-244. PubMed ID: 31953880
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
40. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU
Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
